Skip to main content
Signal8

Kintz Samuel

SEC insider (Form 3/4/5 filer). CIK 0001967168. PRESIDENT AND CEO at Enliven Therapeutics, Inc. (ELVN). 29 reported Form 4/5 transactions since Sep 2024; latest on Nov 17, 2025. Located in BOULDER, CO.

Companies Kintz Samuel has filed insider reports for

  • Enliven Therapeutics, Inc. (ELVN): Director, Officer, PRESIDENT AND CEO
Kintz Samuel profile photo

Kintz Samuel

CIK: 0001967168

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)28 (96.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (3.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Enliven Therapeutics, Inc. logo
ELVN

Enliven Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (29 total)

  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Nov 17, 2025
    Sale
    Indirect
    12.5K shares at avg. $21.82$273K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Oct 17, 2025
    Sale
    Indirect
    12.5K shares at avg. $21.33$267K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Sep 26, 2025
    Sale
    Indirect
    3.7K shares at avg. $20.06$74K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Sep 23, 2025
    Sale
    Indirect
    2.8K shares at avg. $20.03$56K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Sep 19, 2025
    Sale
    Indirect
    1K shares at avg. $20.25$20K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Sep 17, 2025
    Sale
    Indirect
    5K shares at avg. $19.09$95K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Aug 20, 2025
    Sale
    Indirect
    1.5K shares at avg. $20.00$30K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Aug 19, 2025
    Sale
    Indirect
    590 shares at avg. $20.00$12K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Aug 18, 2025
    Sale
    Indirect
    10.4K shares at avg. $20.02$208K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Jul 17, 2025
    Sale
    Indirect
    4.2K shares at avg. $21.58$90K

1-10 of 29